RIPK1/3 |
Receptor-interacting serine/threonine-protein kinase 1/3 |
JNK |
C-Jun N-terminal Kinase |
AP |
Acute pancreatitis |
CP |
Chronic pancreatitis |
PC |
Pancreatic cancer |
TNF-α |
Tumor necrosis factor α |
Fasl |
Fas ligand complex |
LPS |
Lipopolysaccharide |
IFN |
Interferon |
TLR |
Toll-like receptor |
TNFR1 |
Tumor necrosis factor receptor 1 |
ZBP1 |
Z-DNA binding protein 1 |
MLKL |
Mixed lineage kinase ligand |
Nec-1/4 |
Necrostatin-1/4 |
TRADD |
TNFR-associated death domain |
cIAP1/2 |
Cellular inhibitor of apoptosis protein 1/2 |
TRAF2/5 |
TNFR-associated factor 2/5 |
DUBs |
Deubiquitinating enzymes |
NF-κB |
Nuclear factor kappa-B |
Casp-8 |
Caspase-8 |
FADD |
FAS-associated death domain |
RHIMs |
RIP homotypic interaction motifs |
DAMPs |
Damage-associated molecular patterns |
ROS |
Reactive oxygen species |
S161 |
Serine residue 161 |
dsRNA |
Double-stranded RNA |
DAI |
IFN regulatory factor |
ZBP1 |
Z-DNA binding protein 1 |
CYLD |
Cylindromatosis |
miRNAs |
MicroRNAs |
ECM |
Extracellular matrix |
PARP |
Poly(ADP-ribose) collectase |
AIF |
Apoptosis-inducing factor |
TAAs |
Tumor-associated antigens |
NLRP3 |
NOD-like receptor thermal protein domain associated protein 3 |
SAP |
Severe acute pancreatitis |
SAA |
Serum amyloid A |
BMSC |
Bone marrow mesenchymal stem cell |
EUS |
Endoscopic ultrasonography |
S-MRCP |
Contrast-enhanced magnetic resonance cholangiopancreatography |
IHC |
Immunohistochemistry |
WB |
Western blot |
CXCL1/2/5 |
C-X-C motif chemokine ligand 1/2/5 |
APN |
Adiponectin |
ECT |
Electrochemical therapy |
zVAD |
zVAD.fmk |
OS |
Overall survival |
DFS |
Disease-free survival |